These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3677489)

  • 21. Tissue c-myc protein expression and immune response in systemic lupus erythematosus.
    Husby G; Williams RC; Watt RA; West SG; Tung KS
    Clin Exp Immunol; 1987 Sep; 69(3):493-500. PubMed ID: 3311495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption.
    Willeke P; Schlüter B; Schotte H; Erren M; Mickholz E; Domschke W; Gaubitz M
    Lupus; 2004; 13(4):257-62. PubMed ID: 15176662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of cellular oncogenes during rat liver development.
    Zhang XK; Wang Z; Lee A; Huang DP; Chiu JF
    Cancer Lett; 1988 Aug; 41(2):147-55. PubMed ID: 2456853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody to human c-myc oncogene product in autoimmune patients' sera.
    Deguchi Y; Negoro S; Kishimoto S
    Int Arch Allergy Appl Immunol; 1988; 87(3):313-6. PubMed ID: 3060432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
    Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
    Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
    Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients.
    Sarhan RA; Aboelenein HR; Sourour SK; Fawzy IO; Salah S; Abdelaziz AI
    Discov Med; 2015 Jun; 19(107):419-25. PubMed ID: 26175399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus.
    Graninger WB
    Wien Klin Wochenschr; 1992; 104(7):205-7. PubMed ID: 1523845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of c-myc expression early in the course of B-cell activation: studies in normal humans and patients with systemic lupus erythematosus.
    Suzuki H; Nakanishi K; Steinberg A; Green I
    Int Arch Allergy Appl Immunol; 1986; 79(4):380-7. PubMed ID: 3485078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.
    Rönnelid J; Tejde A; Mathsson L; Nilsson-Ekdahl K; Nilsson B
    Ann Rheum Dis; 2003 Jan; 62(1):37-42. PubMed ID: 12480667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
    Husain Z; FitzGerald GB; Wick MM
    J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
    Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
    Front Immunol; 2018; 9():322. PubMed ID: 29545790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).
    Csiszár A; Nagy G; Gergely P; Pozsonyi T; Pócsik E
    Clin Exp Immunol; 2000 Dec; 122(3):464-70. PubMed ID: 11122256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overall Downregulation of mRNAs and Enrichment of H3K4me3 Change Near Genome-Wide Association Study Signals in Systemic Lupus Erythematosus: Cell-Specific Effects.
    Zhang Z; Shi L; Song L; Maurer K; Petri MA; Sullivan KE
    Front Immunol; 2018; 9():497. PubMed ID: 29593737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.